Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

GSK-3β polyclonal antibody

ADI-905-679-100 100 µg 325.00 USD
Do you need bulk/larger quantities?

Product Specification

Alternative Name:Glycogen synthase kinase-3β
Immunogen:Synthetic peptide corresponding to the sequence near the C-terminus of human GSK-3β.
UniProt ID:P49841
Source:Purified from rabbit serum.
Species reactivity:Human, Mouse, Rat
Applications:IHC, WB
Application Notes:Detects a band of ~47kDa by Western blot.
Purity Detail:Protein A affinity purified.
Formulation:Liquid. In PBS, pH 7.2, containing 50% glycerol and 0.09% sodium azide.
Handling:Avoid freeze/thaw cycles.
Shipping:Shipped on Blue Ice
Long Term Storage:-20°C
Scientific Background:Glycogen Synthase Kinase 3β (GSK-3β) is a unique serine/threonine kinase that is inactivated by phosphorylation. In response to insulin binding, PKB/AKT phosphorylates GSK-3β on serine 9, which prevents GSK-3β from phosphorylating glycogen synthase. Unphosphorylated glycogen synthase is active and able to synthesize glycogen. GSK-3β is also unique in that it requires a substrate that has been phosphorylated by a distinct kinase before it can phosphorylate the substrate. This phosphate priming mechanism explains why phosphorylation of serine 9 inactivates GSK-3β. The phosphorylated serine binds to the GSK-3β priming phosphate position and prevents binding of alternative substrates. In addition to insulin signaling, GSK-3β participates in the Wnt signaling pathway, where it forms a complex with axin, beta-catenin and adenomatous polyposis coli (APC) protein. In the presence of Wnts, GSK-3β is unable to phosphorylate beta-catenin, which leads to stabilization of beta-catenin. The Wnt pathway inactivates GSK-3β via the proteins, Dishevelled and FRAT, which disrupt the interaction of GSK-3β with axin, beta-catenin, and APC. Clinically, there is considerable interest in GSK-3β inhibitors because they may mimic the effect of insulin or reduce the hyperphosphorylation of Tau that is observed in Alzheimer's Disease.
Regulatory Status:RUO - Research Use Only
GSK-3β polyclonal antibody Immunohistochemistry
Immunohistochemistry analysis of human hepatoma tissue with GSK3β pAb.
GSK-3β polyclonal antibody Western blot
Western blot analysis of GSK3β pAb. Lane 1: MW marker; Lane 2: HeLa; Lane 3: Jurkat; Lane 4: 3T3; Lane 5: PC-12; Lane 6: MDBK.
Please mouse over
GSK-3β polyclonal antibody Immunohistochemistry GSK-3β polyclonal antibody Western blot

Product Toolbox


Certificate of Analysis


By target:
By biological activity:
GSK Polyclonal antibody
By catalog section:


Technical Service
Customer Service

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

Stem Cells
Stem Cells
Download as PDF

Essential Research Tools for Neurodegeneration & Neural Signaling
Essential Research Tools for Neurodegeneration & Neural Signaling
Download as PDF

All new literature pieces

Recommend this page

For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2020 Enzo Life Sciences, Inc.,